Endogenous nitric oxide and low systemic vascular resistance after cardiopulmonary bypass

被引:35
作者
Myles, PS [1 ]
Leong, CK [1 ]
Currey, J [1 ]
机构
[1] ALFRED HOSP, CARDIOTHORAC INTENS CARE UNIT, PRAHRAN, VIC 3181, AUSTRALIA
关键词
nitric oxide; cardiopulmonary bypass; systemic vascular resistance; cardiac surgery;
D O I
10.1016/S1053-0770(97)90006-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: To investigate the relationship between excessive endogenous production of nitric oxide (NO) and the low systemic vascular resistance (SVR) syndrome after cardiac surgery. Design: Prospective, case-control. Cases defined by low SVR postoperatively (<750 dyn/s/cm(-5)), and matched with controls (> 900 dyn/s/cm(-5)). Setting: Cardiothoracic intensive care unit (ICU) in a tertiary care hospital. Participants: Forty-four patients after cardiac surgery. Interventions: Collection of plasma and urine samples after identification. Measurements and Main Results: Plasma and urine nitrate concentrations were measured as an index of endogenous NO production. Hemodynamic, inotropic, and outcome data were collected. Median nitrate concentrations did not differ between cases and controls (plasma, 58 mu mol/L v62 mu mol/L, p = 0.43; urine, 399 mu mol/L v404 mu mol/L, p = 0.38). Times to extubation and intensive care unit (ICU) discharge were prolonged in patients with low SVR (17.8 hours v8.7 hours, p = 0.021; 2.5 days v1.2 days, p = 0.019, respectively). Conclusions:No association between ''low SVR syndrome'' and endogenous NO production was found. Patients with low SVR after cardiac surgery required a longer period of inotropic and ventilator support, with delay in discharge from the ICU. The risk and cost implications of this syndrome support further research. Copyright (C) 1997 by W.B. Saunders Company.
引用
收藏
页码:571 / 574
页数:4
相关论文
共 29 条
[1]   ASSOCIATION BETWEEN GASTRIC INTRAMUCOSAL PH AND SPLANCHNIC ENDOTOXIN, ANTIBODY TO ENDOTOXIN, AND TUMOR-NECROSIS-FACTOR-ALPHA CONCENTRATIONS IN PATIENTS UNDERGOING CARDIOPULMONARY BYPASS [J].
ANDERSEN, LW ;
LANDOW, L ;
BAEK, L ;
JANSEN, E ;
BAKER, S .
CRITICAL CARE MEDICINE, 1993, 21 (02) :210-217
[2]   NITRIC-OXIDE - MEDIATOR, MURDERER, AND MEDICINE [J].
ANGGARD, E .
LANCET, 1994, 343 (8907) :1199-1206
[3]  
BOOTH BP, 1994, ANESTH ANALG, V78, P848
[4]   CA2+-INDEPENDENT NITRIC-OXIDE SYNTHASE ACTIVITY IN HUMAN LUNG AFTER CARDIOPULMONARY BYPASS [J].
DELGADO, R ;
ROJAS, A ;
GLARIA, LA ;
TORRES, M ;
DUARTE, F ;
SHILL, R ;
NAFEH, M ;
SANTIN, E ;
GONZALEZ, N ;
PALACIOS, M .
THORAX, 1995, 50 (04) :403-404
[5]  
EVANS T, 1993, CIRC SHOCK, V41, P77
[6]   L-ARGININE - NITRIC-OXIDE PATHWAY IN ENDOTOXEMIA AND HUMAN SEPTIC SHOCK [J].
GOMEZJIMENEZ, J ;
SALGADO, A ;
MOURELLE, M ;
MARTIN, MC ;
SEGURA, RM ;
PERACAULA, R ;
MONCADA, S .
CRITICAL CARE MEDICINE, 1995, 23 (02) :253-258
[7]   EVIDENCE FOR CYTOKINE-INDUCIBLE NITRIC-OXIDE SYNTHESIS FROM L-ARGININE IN PATIENTS RECEIVING INTERLEUKIN-2 THERAPY [J].
HIBBS, JB ;
WESTENFELDER, C ;
TAINTOR, R ;
VAVRIN, Z ;
KABLITZ, C ;
BARANOWSKI, RL ;
WARD, JH ;
MENLOVE, RL ;
MCMURRY, MP ;
KUSHNER, JP ;
SAMLOWSKI, WE .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :867-877
[8]   STRATIFICATION OF MORBIDITY AND MORTALITY OUTCOME BY PREOPERATIVE RISK-FACTORS IN CORONARY-ARTERY BYPASS PATIENTS - A CLINICAL SEVERITY SCORE [J].
HIGGINS, TL ;
ESTAFANOUS, FG ;
LOOP, FD ;
BECK, GJ ;
BLUM, JM ;
PARANANDI, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (17) :2344-2348
[9]   ELEVATION OF CYTOKINES DURING OPEN-HEART-SURGERY WITH CARDIOPULMONARY BYPASS - PARTICIPATION OF INTERLEUKIN-8 AND INTERLEUKIN-6 IN REPERFUSION INJURY [J].
KAWAMURA, T ;
WAKUSAWA, R ;
OKADA, K ;
INADA, S .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1993, 40 (11) :1016-1021
[10]   HISTAMINE-RELEASE BY VANCOMYCIN - A MECHANISM FOR HYPOTENSION IN MAN [J].
LEVY, JH ;
KETTLEKAMP, N ;
GOERTZ, P ;
HERMENS, J ;
HIRSHMAN, CA .
ANESTHESIOLOGY, 1987, 67 (01) :122-125